These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Cerebral embolization during transcervical carotid stenting with flow reversal: a diffusion-weighted magnetic resonance study. Faraglia V; Palombo G; Stella N; Rizzo L; Taurino M; Bozzao A Ann Vasc Surg; 2009; 23(4):429-35. PubMed ID: 19041221 [TBL] [Abstract][Full Text] [Related]
26. Carotid stenting with and without protection devices: should protection be used in all patients? Ohki T; Veith FJ Semin Vasc Surg; 2000 Jun; 13(2):144-52. PubMed ID: 10879555 [TBL] [Abstract][Full Text] [Related]
30. A randomized trial of carotid artery stenting with and without cerebral protection. Barbato JE; Dillavou E; Horowitz MB; Jovin TG; Kanal E; David S; Makaroun MS J Vasc Surg; 2008 Apr; 47(4):760-5. PubMed ID: 18295439 [TBL] [Abstract][Full Text] [Related]
31. [Clinical research of carotid artery stenting under the protection of proximal embolic protection device]. Yu B; Wang W; Shi WH; Zhu L; He Q; Tan JY; Wang TP Zhonghua Wai Ke Za Zhi; 2010 Apr; 48(7):526-9. PubMed ID: 20646664 [TBL] [Abstract][Full Text] [Related]
32. A "mouse in a trap" method for cerebral protection during carotid stenting: Technical note. Nishi S; Katsuki T; Mori H; Ohwaki H; Iwasaki K Catheter Cardiovasc Interv; 2004 Feb; 61(2):275-80. PubMed ID: 14755828 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of proximal protection devices during carotid artery stenting as the first choice for embolic protection. Hornung M; Bertog SC; Franke J; Id D; Grunwald I; Sievert H EuroIntervention; 2015 Mar; 10(11):1362-7. PubMed ID: 25042420 [TBL] [Abstract][Full Text] [Related]
34. Design of the rosuvastatin pretreatment to reduce embolization during Carotid Artery Stenting trial. De Carlo M; Cortese B; Pennesi M; Misuraca L; Conte L; Pitì A; Petronio AS; Balbarini A J Cardiovasc Med (Hagerstown); 2014 Jul; 15(7):595-600. PubMed ID: 24922046 [TBL] [Abstract][Full Text] [Related]
35. Preliminary results of carotid artery stenting in a non-academic hospital. Wijtenburg E; Schillaci A; Thomas T; Lismonde M; Remy P; Van Ruyssevelt P Acta Chir Belg; 2007; 107(2):143-5. PubMed ID: 17515261 [TBL] [Abstract][Full Text] [Related]
36. Carotid artery stenting in clinical practice: does sex matter? Results from the carotid artery stenting registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Werner N; Zeymer U; Mark B; Hochadel M; Hauptmann KE; Jung J; Hoffmann E; Elsässer A; Fürste T; Leschke M; Mudra H; Zahn R; Clin Cardiol; 2012 Feb; 35(2):111-8. PubMed ID: 22246970 [TBL] [Abstract][Full Text] [Related]
37. Advantages and indications of transcervical carotid artery stenting with carotid flow reversal. Lo CH; Doblas M; Criado E J Cardiovasc Surg (Torino); 2005 Jun; 46(3):229-39. PubMed ID: 15956920 [TBL] [Abstract][Full Text] [Related]
39. Patient dose during carotid artery stenting with embolic-protection devices: evaluation with radiochromic films and related diagnostic reference levels according to factors influencing the procedure. D'Ercole L; Quaretti P; Cionfoli N; Klersy C; Bocchiola M; Rodolico G; Azzaretti A; Lisciandro F; Cascella T; Zappoli Thyrion F Cardiovasc Intervent Radiol; 2013 Apr; 36(2):320-9. PubMed ID: 23150118 [TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of the effectiveness of distal protection in the prevention of cerebral thromboembolism during carotid stent placement. Martin JB; Murphy KJ; Gailloud P; Sugiu K; Treggiari MM; Muster M; Guimaraens L; Théron JG; Rüfenacht DA Acad Radiol; 2001 Jul; 8(7):623-8. PubMed ID: 11450963 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]